2. Disease Areas
  3. Infection
  4. Bacterial Infection
  5. Listeria Monocytogenes Infection

Listeria Monocytogenes Infection

Listeria monocytogenes infection is a serious foodborne illness caused by a gram-positive, facultative anaerobic intracellular bacterium capable of surviving and growing under refrigeration and in low-moisture, high-salt environments. It is primarily transmitted through contaminated food and can lead to severe clinical outcomes including sepsis, meningitis, and adverse maternal–neonatal events such as abortion, stillbirth, and neonatal listeriosis. While most cases present as mild febrile gastroenteritis, invasive disease is more common in high-risk groups including pregnant women, neonates, the elderly, immunocompromised individuals, and those with chronic conditions like diabetes, cancer, HIV, liver or kidney disease, and organ transplant recipients. Despite advances in food safety and public health education leading to declining incidence rates, listeriosis remains associated with significant morbidity and mortality, with overall case-fatality rates around 26%, rising to 46% in neonates. Mortality risk factors remain poorly defined, highlighting the need for further research into demographic, comorbid, and clinical determinants of fatal outcomes in listeriosis.

Listeria Monocytogenes Infection (4):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-Y1329
    Trisodium phosphate 7601-54-9 99.50%
    Trisodium phosphate is a food additive. Trisodium phosphate affects the growth parameters (lag phase, maximum growth rate) of Listeria monocytogenes and increases the sensitivity of Gram-negative bacteria to Lysozyme (HY-P1068) and Nisin (HY-P1607).
    Trisodium phosphate
  • HY-W039699
    2-(p-Tolyl)propanoic acid 938-94-3
    2-(p-Tolyl) propanoic acid (2-(4-methylphenyl) propionic acid) acts as an Antimicrobial agent intermediate. 2-(p-Tolyl) propanoic acid inhibits COX-1 and COX-2 enzymes, with IC50 values of 38.23 μM and 64.30 μM, respectively. 2-(p-Tolyl) propanoic acid is applicable to research on E. coli, Enterococcus faecalis, Listeria monocytogenes, and Staphylococcus aureus.
    2-(p-Tolyl)propanoic acid
  • HY-181686
    Antibacterial agent 326
    Antibacterial agent 326 is a bactericide that inhibits the growth of various bacterial strains. Antibacterial agent 326 inhibits biofilm formation in Escherichia coli, disrupts bacterial cell membranes, induces oxidative stress and lipid peroxidation in Escherichia coli, increases ROS levels, and reduces GSH activity. Antibacterial agent 326 can be used in studies of bacterial infections, including those caused by Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Listeria spp., Bacillus subtilis, Serratia marcescens, Salmonella enteritidis and Acinetobacter calcoaceticus.
    Antibacterial agent 326
  • HY-P11187A
    Bactofencin A acetate 99.26%
    Bactofencin A acetate is a class IId bacteriocin and Antibacterial agent. Bactofencin A acetate is produced by Lactobacillus salivarius DPC6502, an isolate derived from the intestine. Bactofencin A acetate exhibits activity against Staphylococcus and Listeria species. Bactofencin A acetate slightly modulates the intestinal flora. Bactofencin A acetate can be used in research related to staphylococcal infections, listerial infections, and mastitis.
    Bactofencin A acetate